synthesi
sever
amin
methyl
amin
amin
methyl
amin
report
evalu
wide
rang
virus
one
inhibit
cytopath
influenza
viru
concentr
similar
amantadin
sever
new
polycycl
amin
show
interest
activ
nmda
receptor
antagonist
rimantadin
analogu
display
signific
trypanocid
activ
moreov
character
pharmacolog
compound
effect
dopamin
uptak
also
assess
amantadin
methylamin
rimantadin
prophylact
therapeut
activ
influenza
viru
infect
relat
adamantan
deriv
also
show
antivir
activ
adamantan
deriv
inexpens
resist
drug
develop
readili
treatment
frequent
complic
central
nervou
system
cn
sideeffect
fact
amantadin
analogu
memantin
nmda
receptor
antagonist
approv
treatment
parkinson
alzheim
diseas
respect
thu
design
new
amantadinerel
antiinfluenza
agent
without
cn
sideeffect
highli
desir
goal
amantadin
rimantadin
memantin
relat
polycycl
amin
also
possess
trypanocid
activ
fig
biolog
activ
also
found
polycycl
cage
amin
exampl
compound
antiinfluenza
activ
maob
inhibitor
nmda
receptor
antagonist
fig
year
two
us
pc
sv
work
project
aim
explor
structur
reactiv
noradamantan
bisnoradamantan
deriv
work
topic
done
pure
synthet
point
view
exampl
develop
sever
gener
entri
skeleton
howev
systemat
studi
direct
toward
synthesi
biolog
activ
noradamantan
bisnoradamantan
deriv
yet
carri
fig
well
known
medicin
chemistri
drug
contain
cyclic
system
gener
worth
synthes
analogu
ring
open
expand
contract
one
unit
analogu
show
similar
activ
parent
compound
tricyclo
amin
tricyclo
amin
may
view
ring
contract
analog
amantadin
featur
skeleton
one
two
carbon
less
model
respect
reason
paper
describ
prepar
seri
amin
amin
relat
compound
well
result
antivir
trypanocid
nmda
receptor
antagonist
dopamin
reuptak
inhibitori
activ
start
known
amin
prepar
noradamantan
amin
use
classic
method
amin
chemistri
thu
reduct
alkyl
sever
aromat
aldehyd
afford
secondari
amin
moder
high
yield
dimethyl
deriv
prepar
previous
describ
literatur
monomethyl
deriv
synthes
reduct
alkyl
follow
catalyt
debenzyl
good
overal
yield
final
piperidin
deriv
prepar
alkyl
primari
amin
yield
scheme
start
known
amid
seri
noradamantyl
methylamin
synthes
thu
reduct
amid
lialh
follow
acid
workup
led
hydrochlorid
amin
yield
reduct
alkyl
benzaldehyd
nacnbh
methanol
gave
yield
reduct
methyl
follow
catalyt
hydrogen
led
high
yield
reduct
methyl
formic
acid
formaldehyd
furnish
dimethyl
deriv
yield
final
reaction
led
guanidin
yield
scheme
hand
start
known
acid
prepar
amin
use
classic
method
amin
chemistri
although
synthesi
amin
acid
low
yield
use
classic
schmid
curtiu
reaction
yield
respect
applic
yamada
modif
curtiu
reaction
allow
us
obtain
fulli
character
hydrochlorid
amin
yield
amin
reduct
alkyl
benzaldehyd
led
yield
similarli
reduct
alkyl
led
yield
reduct
methyl
follow
catalyt
debenzyl
furnish
secondari
amin
high
yield
dimethyl
deriv
obtain
yield
treat
amin
excess
formic
acid
formaldehyd
final
dibenzyl
compound
prepar
doubl
alkyl
benzyl
chlorid
yield
scheme
moreov
reaction
methyllithium
gave
keton
low
yield
reaction
hydroxylamin
follow
reduct
obtain
oxim
lialh
gave
amin
compound
view
ring
contract
analog
antivir
rimantadin
scheme
final
reduct
amid
easili
avail
acid
lialh
follow
acid
workup
gave
hydrochlorid
amin
overal
yield
follow
similar
sequenc
previous
use
amin
amin
obtain
high
yield
piperidin
deriv
obtain
alkyl
amin
yield
final
reaction
led
guanidin
yield
scheme
structur
new
compound
confirm
element
analysi
accur
mass
measur
ir
h
nmr
c
nmr
mass
spectral
data
tsets
flytransmit
protozoan
parasit
trypanosoma
brucei
caus
agent
human
african
trypanosomiasi
hat
major
upsurg
diseas
late
throughout
mani
part
subsaharan
africa
annual
infect
fallen
result
major
surveil
treatment
programm
howev
million
peopl
remain
risk
area
death
rate
exceed
hivaid
malaria
drug
current
avail
treat
hat
requir
administr
medic
supervis
character
limit
efficaci
toxic
resist
exampl
arsen
drug
melarsoprol
use
treat
late
stage
diseas
result
reactiv
encephalopathi
kill
patient
absenc
treatment
hat
invari
fatal
new
drug
therefor
urgent
requir
recent
report
antiinfluenza
viru
drug
rimantadin
activ
vitro
bloodstream
form
brucei
aminoadamantan
deriv
enhanc
activ
extend
observ
test
sever
new
bisnoradamantan
relat
compound
activ
bloodstream
form
brucei
noradamantylamin
methyl
amin
describ
paper
birnoradamantyl
deriv
found
signific
activ
cultur
bloodstream
brucei
concentr
lg
ml
compound
show
transient
effect
growth
lg
ml
cell
grew
normal
densiti
rimantadin
analog
activ
compound
test
establish
ic
lm
ic
lm
valu
amin
found
slightli
activ
rimantadin
ic
lm
ic
lm
least
time
activ
amantadin
ic
lm
nmda
receptor
antagonist
highli
interest
compound
sinc
receptor
involv
sever
neurodegen
disord
fact
memantin
wide
use
therapeut
slow
progress
alzheim
diseas
activ
differ
new
polycycl
compound
assay
cerebellar
granul
neuron
load
calciumsensit
probe
addit
glutam
nmda
lm
presenc
glycin
lm
produc
robust
stabl
increas
intracellular
calcium
challeng
cumul
addit
compound
test
although
noradamantyl
deriv
sever
bisnoradamantyl
compound
abl
inhibit
calcium
entri
nmda
receptor
none
compound
potent
memantin
glutamateor
nmdainduc
calcium
increas
cerebellar
granul
neuron
tabl
gener
bisnoradamantan
deriv
potent
nmda
receptor
antagonist
noradamantan
amin
exampl
amin
time
potent
nmda
receptor
antagonist
guanidin
deriv
time
potent
correspond
noradamantyl
analog
bisnoradamantylamin
usual
activ
correspond
bisnoradamantyl
methylamin
analog
exemplifi
pair
alkyl
substitut
caus
reduct
potenc
eg
seri
guanidin
deriv
potent
compound
time
potent
amantadin
time
less
potent
memantin
attempt
synthes
guanidin
deriv
success
none
synthes
compound
found
antivir
activ
envelop
dna
virus
herp
simplex
viru
type
type
vaccinia
viru
envelop
rna
virus
felin
coronaviru
viru
respiratori
syncyti
viru
vesicular
stomat
viru
sindbi
viru
punta
toro
viru
nonenvelop
rna
virus
coxsackieviru
influenza
viru
assay
compound
two
primari
amin
display
reason
activ
influenza
subtyp
secondari
tertiari
amin
activ
tabl
antivir
data
obtain
microscopi
confirm
colorimetr
cell
viabil
assay
data
shown
highest
select
note
compound
test
subtyp
anticip
compound
prove
inact
influenza
b
viru
known
insensit
amantadin
rimantadin
known
amantadin
increas
extracellular
dopamin
level
antagon
nmda
receptor
although
exact
mechan
fulli
elucid
sever
new
amin
show
nmda
receptor
antagonist
activ
ic
similar
even
lower
amantadin
determin
effect
h
dopamin
uptak
rat
striatal
synaptosom
tabl
concentr
test
lm
sever
compound
abl
inhibit
h
dopamin
uptak
manner
show
ing
similar
valu
inhibit
amantadin
memantin
howev
seem
correl
exist
potenc
antagonist
nmda
receptor
probabl
mechan
involv
regul
dopamin
releas
like
differ
activ
receptor
inhibit
dopamin
transport
summari
synthes
fulli
character
sever
amin
methylamin
amin
methylamin
although
compound
less
potent
memantin
nmdainduc
calcium
increas
cerebellar
granul
neuron
sever
compound
potent
amantadin
bisnoradamantan
amin
potent
correspond
noradamantan
amin
interestingli
none
compound
show
antivir
activ
compound
display
reason
activ
influenza
subtyp
show
nmda
receptor
antagonist
activ
moreov
none
compound
significantli
potent
test
concentr
amantadin
memantin
inhibitor
dopamin
uptak
amantadin
display
antiinfluenza
activ
nmda
receptor
antagon
select
usual
highli
desir
drug
amin
herein
report
open
way
design
new
aminopolycycl
compound
select
antiinfluenza
nmda
receptor
antagonist
activ
interestingli
amin
time
potent
amantadin
nmda
receptor
antagonist
also
display
trypanocid
activ
slightli
activ
rimantadin
least
time
activ
amantadin
guanidin
polycycl
cage
compound
select
nmda
receptor
antagonist
activ
ic
lm
without
antivir
trypanocid
activ
synthesi
pharmacolog
evalu
polycycl
cage
amin
progress
reach
potent
select
deriv
melt
point
determin
open
capillari
tube
unless
otherwis
state
nmr
spectra
record
cd
od
follow
spectromet
h
nmr
mhz
c
nmr
mhz
chemic
shift
report
ppm
relat
intern
tetramethylsilan
tm
assign
given
nmr
spectra
base
dept
cosi
h
h
hetcor
h
c
hsqc
hmbc
sequenc
one
bond
long
rang
h
c
heterocorrel
respect
noesi
experi
select
compound
ms
gcm
analys
sampl
introduc
directli
ga
chromatograph
gcm
analys
column
dimethylpolysiloxan
condit
psi
initi
temperatur
min
heat
rang
till
isotherm
use
electron
impact
ev
chemic
ioniz
ch
techniqu
use
signific
ion
given
higher
rel
ratio
except
ion
higher
mz
valu
accur
mass
measur
obtain
use
esi
technic
absorpt
valu
ir
spectra
kbr
given
wavenumb
cm
column
chromatographi
perform
silica
gel
mesh
thinlay
chromatographi
tlc
aluminumback
sheet
silica
gel
f
use
spot
visual
uv
light
andor
aqueou
solut
kmno
solut
mg
mmol
meoh
ml
nabh
cn
mg
mmol
acoh
ml
benzaldehyd
ml
mmol
ad
mixtur
stir
room
temperatur
h
addit
portion
nabh
cn
mg
mmol
benzaldehyd
ml
mmol
ad
mixtur
stir
room
temperatur
overnight
concentr
dryness
water
ml
ad
residu
suspens
basifi
n
naoh
extract
etoac
ml
combin
organ
extract
wash
brine
ml
dri
anhyd
na
filter
concentr
vacuo
residu
taken
etoac
amin
precipit
hydrochlorid
mg
yield
ad
excess
et
analyt
sampl
obtain
crystal
meoh
mp
dec
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
mg
mmol
nabh
cn
mg
mmol
acoh
ml
ml
mmol
meoh
ml
follow
procedur
obtain
mg
yield
analyt
sampl
obtain
crystal
mp
dec
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
n
cl
found
c
h
n
cl
n
tricyclo
amin
hydrochlorid
mg
mmol
nabh
cn
mg
mmol
acoh
ml
ml
mmol
meoh
ml
follow
procedur
describ
obtain
mg
yield
analyt
sampl
obtain
crystal
mp
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
n
cl
found
c
h
n
cl
mg
mmol
nabh
cn
mg
mmol
acoh
ml
ml
mmol
meoh
ml
follow
procedur
describ
obtain
mg
yield
analyt
sampl
obtain
crystal
mp
dec
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
mg
mmol
nabh
cn
mg
mmol
acoh
ml
ml
mmol
meoh
ml
follow
procedur
describ
obtain
mg
yield
analyt
sampl
obtain
crystal
ethyl
acet
mp
dec
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
n
cl
f
found
c
h
n
cl
f
mg
mmol
nabh
cn
mg
mmol
acoh
ml
ml
mmol
meoh
ml
follow
procedur
describ
obtain
mg
yield
analyt
sampl
obtain
crystal
etoac
mp
dec
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
cm
solut
mg
mmol
acetonitril
ml
formaldehyd
ml
wt
water
solut
mmol
nabh
cn
mg
mmol
ad
mixtur
stir
min
room
temperatur
acoh
ml
ad
mixtur
stir
room
temperatur
h
addit
portion
nabh
cn
mg
mmol
ad
mixtur
stir
room
temperatur
h
mixtur
concentr
dryness
n
naoh
ml
ad
suspens
extract
ch
cl
ml
combin
organ
phase
wash
h
ml
dri
anhyd
na
filter
concentr
vacuo
residu
taken
etoac
amin
precipit
hydrochlorid
mg
yield
ad
excess
et
analyt
sampl
obtain
crystal
mp
dec
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
anal
calcd
c
h
c
h
n
cl
found
c
h
n
cl
piperidin
hydrochlorid
solut
mg
mmol
dmf
ml
anhyd
et
n
ml
mmol
ad
suspens
stir
room
temperatur
h
ml
mmol
ad
mixtur
heat
h
cold
mixtur
water
ml
ad
solut
wash
etoac
ml
aqueou
phase
basifi
n
naoh
ml
extract
ethyl
acet
ml
combin
organ
extract
wash
water
ml
dri
anhyd
na
filter
excess
et
ad
solut
concentr
vacuo
dryness
give
mg
yield
analyt
sampl
obtain
crystal
meohet
mp
dec
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
cm
h
nmr
dm
j
hz
h
ax
dquint
j
hz
n
found
c
h
n
amin
hydrochlorid
solut
mg
mmol
pdc
water
mg
absolut
etoh
ml
hydrogen
atm
h
suspens
filter
residu
wash
etoh
organ
layer
concentr
vacuo
give
solid
crystal
meohet
gave
mg
yield
mp
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
n
found
c
h
n
tricyclo
methyl
amin
hydrochlorid
cold
solut
mg
mmol
anhyd
thf
ml
lialh
mg
mmol
ad
suspens
heat
reflux
h
suspens
cool
ice
bath
care
basifi
n
naoh
ml
stir
h
room
temperatur
precipit
filter
wash
ch
cl
ml
combin
filtrat
wash
dri
anhyd
na
filter
excess
et
ad
solut
concentr
vacuo
give
solid
crystal
meohet
give
mg
yield
mp
dec
ir
h
c
h
n
cl
found
c
h
n
cl
methyl
amin
hydrochlorid
mg
mmol
meoh
ml
nabh
cn
mg
mmol
acoh
ml
benzaldehyd
ml
mmol
addit
portion
nabh
cn
mg
mmol
benzaldehyd
ml
mmol
follow
procedur
describ
obtain
mg
yield
analyt
sampl
obtain
crystal
etoac
mp
dec
ir
ir
ir
ir
ir
n
cl
found
c
h
n
cl
methyl
amin
hydrochlorid
mg
mmol
acetonitril
ml
formaldehyd
ml
wt
water
solut
mmol
two
portion
nabh
cn
mg
mmol
follow
procedur
describ
amin
obtain
mg
yield
hydrochlorid
obtain
ad
excess
et
solut
amin
etoac
follow
concentr
vacuo
dryness
analyt
sampl
obtain
crystal
etoac
mp
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
h
j
hz
ch
n
j
hz
ch
b
n
j
hz
ch
c
h
j
hz
ch
b
c
h
h
h
c
h
n
cl
found
c
h
n
cl
n
methyl
amin
hydrochlorid
cold
solut
mg
mmol
et
ml
formaldehyd
ml
wt
water
solut
mmol
dropwis
formic
acid
ml
mmol
ad
mixtur
stir
h
cold
mixtur
et
ml
ad
n
naoh
ml
ad
dropwis
suspens
stir
room
temperatur
min
organ
layer
separ
aqueou
phase
extract
et
ml
combin
organ
phase
dri
anhyd
na
filter
excess
et
ad
concentr
vacuo
gave
mg
yield
analyt
sampl
obtain
crystal
meohet
mp
dec
ir
kbr
ch
n
ch
anal
calcd
c
h
c
h
n
cl
found
c
h
n
cl
methyl
guanidin
hydrochlorid
cold
solut
mg
mmol
acetonitril
ml
anhyd
et
n
ml
mmol
hydrochlorid
mg
mmol
ad
suspens
heat
h
cool
h
precipit
filter
wash
cold
acetonitril
ml
give
mg
yield
product
taken
etoac
excess
et
ad
solvent
elimin
vacuo
analyt
sampl
obtain
crystal
meohet
mp
ir
kbr
h
n
cl
found
c
h
n
cl
methyl
amin
hydrochlorid
mg
mmol
pdc
water
mg
absolut
etoh
ml
follow
procedur
describ
mg
yield
obtain
crystal
meohet
mp
dec
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
solut
acid
mg
mmol
toluen
ml
et
n
ml
mmol
diphenylphosphorylazid
mg
mmol
ad
mixtur
heat
reflux
h
cold
icebath
solut
wash
cold
n
hcl
ml
n
hcl
ml
ad
organ
solut
mixtur
heat
reflux
h
organ
layer
separ
aqueou
layer
wash
et
ml
water
remov
freezedry
give
white
solid
mg
yield
analyt
sampl
obtain
crystal
water
mp
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
n
cl
found
c
h
n
cl
amin
hydrochlorid
solut
mg
mmol
meoh
ml
nabh
cn
mg
mmol
acoh
ml
benzaldehyd
mg
mmol
ad
mixtur
stir
room
temperatur
h
solut
concentr
dryness
water
ml
ad
residu
mixtur
extract
et
ml
combin
organ
extract
wash
n
naoh
ml
brine
ml
dri
anhyd
na
concentr
vacuo
residu
subject
column
chromatographi
silica
gel
hexan
etoac
give
amin
mg
yield
analyt
sampl
obtain
ad
excess
et
solut
etoac
filtrat
form
precipit
mp
dec
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
cm
h
nmr
n
cl
found
c
h
n
cl
n
tricyclo
amin
hydrochlorid
mg
mmol
nabh
cn
mg
mmol
acet
acid
ml
ml
mmol
methanol
ml
follow
procedur
mg
yield
obtain
analyt
sampl
obtain
crystal
meoh
et
mp
dec
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
ir
cm
h
nmr
h
c
nmr
ch
ch
ch
ch
n
ch
c
ch
ch
c
ch
ch
n
amin
hydrochlorid
mixtur
mg
mmol
k
co
g
mmol
benzyl
chlorid
ml
mmol
nai
mg
mmol
acetonitril
ml
heat
reflux
h
mixtur
concentr
vacuo
etoac
ml
ad
residu
organ
solut
wash
water
ml
dri
anhi
na
concentr
vacuo
residu
subject
column
chromatographi
silica
gel
hexaneetoac
give
amin
mg
yield
analyt
sampl
obtain
ad
excess
et
solut
etoac
filtrat
form
precipit
mp
ir
antivir
activ
compound
determin
establish
cell
cultur
assay
use
select
dna
rna
virus
includ
three
subtyp
influenza
viru
apuerto
ahong
bhong
kong
compound
inhibitori
effect
viru
replic
well
cytotox
monitor
microscop
examin
confirm
colorimetr
mt
cell
viabil
assay
femal
wistar
rat
g
use
throughout
briefli
rat
kill
decapit
striatum
dissect
homogen
volum
wv
sucros
use
potterelvejhem
result
crude
synaptosom
prepar
centrifug
min
supernat
store
pellet
resuspend
volum
sucros
recentrifug
two
supernat
combin
mixtur
centrifug
min
result
pellet
suspend
volum
icecold
kreb
medium
protein
concentr
determin
use
bradford
protein
assay
h
dopamin
uptak
evalu
aliquot
synaptosom
prepar
min
preincub
kreb
buffer
contain
lm
pargylin
block
metabol
dopamin
monoamin
oxidas
h
dopamin
cimmol
amersham
ad
final
nm
concentr
ten
minut
incub
stop
dilut
icecold
kreb
medium
sampl
filter
rapidli
grade
fiberglass
filter
schleicher
schuell
use
brandel
cell
harvest
model
biochem
research
develop
laboratori
inc
filter
wash
twice
ml
cold
kreb
medium
dri
nonspecif
h
da
uptak
determin
duplic
sampl
presenc
lm
nomifensin
dopamin
uptak
inhibitor
filter
place
scintil
mixtur
optiphas
hisaf
perkinelm
radioact
determin
scintil
spectrometri
